Sperimentazione in fase di reclutamento = ; Sperimentazione in corso = ; Finanziato da un ente associato a IRDiRC =

Sperimentazioni cliniche nazionali

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

CaspaCide TCR α β haplo HSCT: Follow-up of Phase 1/2 Study of CaspaCIDe T Cells (BPX-501) From an HLA-partially Matched Family Donor After Negative Selection of TCR α β+T Cells in Pediatric Patients Affected by Hematological Disorders-GB

GOSH NHS Foundatin Trust

Great Ormond Street Hospital

Ulteriori dettagli

Sperimentazioni cliniche internazionali

STATI UNITI

Texas
HOUSTON

CaspaCide TCR α β haplo HSCT: Follow-up of Phase 1/2 Study of CaspaCIDe T Cells (BPX-501) From an HLA-partially Matched Family Donor After Negative Selection of TCR α β+T Cells in Pediatric Patients Affected by Hematological Disorders

Bellicum Pharmaceuticals, Inc.

Ulteriori dettagli